Related content

Effects of anandamide in migraine: data from an animal model

By Greco Rosaria   Mangione Antonina   Sandrini Giorgio   Maccarrone Mauro   Nappi Giuseppe   Tassorelli Cristina  

The Journal of Headache and Pain, Vol. 12, Iss. 2, 2011-04 ,pp. : 177-183

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Migraine in the Early Stages of an Attack: A Prospective, Double-blind, Placebo-controlled Trial of Eletriptan

By Brandes J.   Hilliard B.   Sikes C.   Tiseo P.  

Headache Care, Vol. 1, Iss. 4, 2004-12 ,pp. : 285-288

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of a Comprehensive Physician and Patient Education Programme for the Treatment of Migraine: Interim Results from the Mercy Migraine Management Project

By Smith Timothy R.  

Headache Care, Vol. 1, Iss. 3, 2004-08 ,pp. : 195-198

Informa Healthcare

Access to resources Recommend Favorite

Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study

By Tfelt-Hansen P.   Bach F.   Daugaard D.   Tsiropoulos I.   Riddersholm B.  

The Journal of Headache and Pain, Vol. 7, Iss. 6, 2006-12 ,pp. : 389-394

Springer Publishing Company

Access to resources Recommend Favorite

Spotlight on the treatment of migraine

By Strupp Michael  

Journal of Neurology, Vol. 251, Iss. 5, 2004-05 ,pp. : 642-644

Springer Publishing Company

Access to resources Recommend Favorite